$21.84
+1.0%Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Chief Administrative Officer, Executive Vice President, General Counsel & Secretary
Compensation
$1,621,052
Chief Executive Officer & Executive Chairman
Compensation
$980,000
Executive Vice President, Treasurer & Chief Financial Officer
Compensation
$953,071
President of South Central Division
President of West Division
Senior Vice President & Chief Accounting Officer
Compensation
$931,198
Senior Vice President & Chief Information Officer
Senior Vice President of Administration & Managed Care
Senior Vice President of Operations
Senior Vice President of People Services
During the last 12 months, insiders have sold $1.83M worth of MD shares, with no buying activity reported.
0
0.00
36.0K
855.66K
-856K
-$856K
0
0.00
23.0K
515.43K
-515K
-$515K
0
0.00
20.5K
457.49K
-457K
-$457K
0
0.00
0
0.00
+0
+$0
No buying activity
Weis Shirley A
Director
$856K
Ordan Mark S
Director, Officer: Chief Executive Officer
$515K
Rucker Michael A.
Director
$241K
Linynsky Laura A
Director
$217K
Strong bearish signal with $1.83M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
MD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | March 25, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 28, 2025 | March 26, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 28, 2024 | May 09, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 31, 2023 | March 31, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 01, 2022 | May 12, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 23, 2021 | May 12, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | July 28, 2020 | September 09, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 29, 2019 | May 16, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 23, 2018 | May 16, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 17, 2017 | May 11, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.